Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
-
Published:2024-01
Issue:
Volume:196
Page:113439
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Li Jian, Zhang Jun, Zhang Yanqiao, Qiu Haibo, Zhou Yanbing, Zhou Yongjian, Zhang Xinhua, Zhou Ye, Zhu Yuping, Li Yong, Wang Ming, Shen Kuntang, Tao Kaixiong, Wu Xin, Wang Haijiang, Zhang Bo, Ling Jiayu, Ye Yingjiang, Wu Xingye, Qu Hongyan, Ma Yue, Jiao Xuelong, Zheng Hualong, Jin JiejieORCID, Liu Zhuo, Tan Ming, Fang Yong, Zhang Peng, Zhang Nan, Lei Cheng, Cai ZhaolunORCID, Liang Bin, Peng Zhangyan, Huang Zhao, Dong Juan, Shen Lin
Subject
Cancer Research,Oncology
|
|